Highlights Sirio Pharma Co., Ltd.

Equities

300791

CNE100003NB0

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 02/06/2024 BST			5-day change	1st Jan Change
39.69 ^CNY	+1.77%		-0.63%	+14.51%

04-21	Sirio Pharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-19	Tranche Update on Sirio Pharma Co., Ltd.'s Equity Buyback Plan announced on September 15, 2023.	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sirio Pharma Co., Ltd. Approves Cash Dividend for 2023	05-29	CI
Sirio Pharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-20	CI
Tranche Update on Sirio Pharma Co., Ltd.'s Equity Buyback Plan announced on September 15, 2023.	03-19	CI
Sirio Pharma Co., Ltd.'s Equity Buyback announced on September 15, 2023, has closed with 1,285,600 shares, representing 0.71% for CNY 39.9 million.	03-17	CI
Tranche Update on Sirio Pharma Co., Ltd.'s Equity Buyback Plan announced on September 15, 2023.	01-02	CI
Sirio Pharma Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	25/10/23	CI
Sirio Pharma Co., Ltd. announces an Equity Buyback for CNY 40 million worth of its shares.	15/09/23	CI
Sirio Pharma Co., Ltd. authorizes a Buyback Plan.	13/09/23	CI
Sirio Pharma Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24/08/23	CI
Sirio Pharma Co., Ltd. Announces Implementation of Cash Dividend for the Year 2022, Payable on June 07, 2023	01/06/23	CI
Sirio Pharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23	CI
Sirio Pharma Co., Ltd. Proposes Profit Distribution Proposal of Cash Dividend for the Year 2022	21/04/23	CI
Sirio Pharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	20/04/23	CI
Sirio Pharma Cancels Planned 1.35 Billion Yuan Share Sale to Fund Aquisition	09/12/22	MT
Sirio Pharma Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	25/10/22	CI
Sirio Pharma Co., Ltd. acquired 80% stake in Best Formulations Inc. from m Eugene C. Ung, Kelly C. Ung, Charles C. Ung, Peak Trust Company-NV, Jeffrey A. Goh, and Joy S. Hsu.	16/10/22	CI
Sirio Pharma Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	25/08/22	CI
Sirio Pharma to Buy 80% of US Rival Best Formulations for $180 Million; Shares Slump 4%	11/07/22	MT
Sirio Pharma Co., Ltd. agreed to acquire 80% stake in Ultimate Formulations, Inc.	06/07/22	CI
Sirio Pharma Co., Ltd. Announces Final Profit Distribution Plan for 2021 on A Shares, Payable on 23 May 2022	17/05/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Sirio Pharma Co., Ltd.

Equities

300791

CNE100003NB0

Highlights

Filters